Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Feb-25-06 | Feb-26-05 | Feb-28-04 |
| 10-K | 10-K | 10-K |
Revenues: |
United States | 667.2 | 599.9 | 531.8 |
Other foreign | 341.8 | 427.0 | 279.9 |
Brazil | 148.6 | 93.1 | 106.9 |
Poland | 77.4 | 68.5 | 47.1 |
Other | 69.8 | 68.7 | 85.6 |
Total revenues | 1,304.8 | 1,257.2 | 1,051.3 |
Revenue growth [+] | 3.8% | 19.6% | |
United States | 11.2% | 12.8% | |
Other foreign | -20.0% | 52.6% | |
Brazil | 59.7% | -12.9% | |
Poland | 12.9% | 45.4% | |
United Kingdom | 1.6% | -19.7% | |
Cost of goods sold | 104.0 | 158.0 | 59.2 |
Gross profit | 1,200.8 | 1,099.3 | 992.1 |
Gross margin | 92.0% | 87.4% | 94.4% |
Selling, general and administrative | 135.7 | 117.3 | 109.1 |
Research and development | 49.9 | 52.6 | 57.3 |
Equity in earnings | 1.9 | 2.8 | 6.2 |
Other operating expenses | 674.5 | 616.6 | 537.8 |
EBITDA [+] | 509.5 | 461.6 | 409.4 |
EBITDA growth | 10.4% | 12.8% | |
EBITDA margin | 39.0% | 36.7% | 38.9% |
Depreciation | 166.8 | 146.0 | 115.3 |
EBITA | 342.8 | 315.6 | 294.1 |
EBITA margin | 26.3% | 25.1% | 28.0% |
Amortization of intangibles | 0.2 | | |
EBIT [+] | 342.6 | 315.6 | 294.1 |
EBIT growth | 8.5% | 7.3% | |
EBIT margin | 26.3% | 25.1% | 28.0% |
Interest expense, net [+] | 19.9 | 14.6 | 5.2 |
Interest expense | 30.8 | 19.2 | 10.9 |
Interest income | 10.9 | 4.6 | 5.7 |
Other income (expense), net | -4.3 | 5.4 | 1.9 |
Pre-tax income | 318.4 | 306.4 | 290.8 |
Income taxes | 107.3 | 110.0 | 107.6 |
Tax rate | 33.7% | 35.9% | 37.0% |
Net income | 211.0 | 196.4 | 183.2 |
Net margin | 16.2% | 15.6% | 17.4% |
|
Basic EPS [+] | $1.73 | $1.68 | $1.57 |
Growth | 2.9% | 6.9% | |
Diluted EPS [+] | $1.62 | $1.48 | $1.38 |
Growth | 9.3% | 7.3% | |
|
Shares outstanding (basic) [+] | 121.9 | 116.7 | 116.5 |
Growth | 4.4% | 0.2% | |
Shares outstanding (diluted) [+] | 130.4 | 132.6 | 132.6 |
Growth | -1.6% | 0.0% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|